(Q37894984)

English

Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project

scientific article published on July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alessandra Pigni

object named as

Alessandra Pigni

2

0 references

Cinzia Brunelli

object named as

Cinzia Brunelli

3

0 references

Augusto Caraceni

object named as

Augusto Caraceni

1

0 references

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Palliative Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

402-409

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Morphine and alternative opioids in cancer pain: the EAPC recommendations

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Oral morphine for cancer pain

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature.

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Buprenorphine in long-term control of chronic pain in cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Morphine or oxycodone in cancer pain?

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Controlled-release oxycodone and morphine in cancer related pain.

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A randomized study on oral administration of morphine and methadone in the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Morphine and oxycodone hydrochloride in the management of cancer pain.

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Treatment of cancer pain with transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer

1 reference

https://api.crossref.org/works/10.1177%2F0269216310392102

21 January 2018

Identifiers

10.1177/0269216310392102

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37894984&oldid=1754242652"